VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $183,000 | -57.2% | 12,669 | -50.6% | 0.01% | -58.3% |
| Q2 2017 | $428,000 | +205.7% | 25,633 | +74.9% | 0.01% | +200.0% |
| Q1 2017 | $140,000 | -22.2% | 14,655 | +24.6% | 0.00% | -33.3% |
| Q4 2016 | $180,000 | -20.7% | 11,765 | +23.2% | 0.01% | -33.3% |
| Q3 2016 | $227,000 | -3.0% | 9,552 | -6.2% | 0.01% | 0.0% |
| Q2 2016 | $234,000 | +15.3% | 10,188 | +410.9% | 0.01% | -10.0% |
| Q4 2015 | $203,000 | -46.3% | 1,994 | -5.9% | 0.01% | -52.4% |
| Q3 2015 | $378,000 | +58.2% | 2,118 | +27.0% | 0.02% | +40.0% |
| Q4 2014 | $239,000 | 0.0% | 1,668 | -8.6% | 0.02% | -11.8% |
| Q3 2014 | $239,000 | -48.9% | 1,824 | -48.6% | 0.02% | -65.3% |
| Q1 2014 | $468,000 | – | 3,549 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |